-
Current guidelines recommend mitral-valve surgery for severe organic mitral regurgitation in asymptomatic patients if exercise pulmonary hypertension (PASP > 60 mmHg) is demonstrated.
-
The dispatcher-assisted resuscitation trial (DART) tested the hypothesis that 911 dispatcher instructions to provide chest compressions only would be superior to similar instructions that included both chest compressions and rescue breathing.
-
There is considerable concern regarding in-stent thrombosis of drug-eluting stents (DES) when aspirin and clopidogrel are stopped for non-cardiac surgery (NCS), but a paucity of data.
-
Although ischemic left ventricular (LV) dysfunction is an indication for revascularization, little is known about the long-term benefits of revascularization and the value of viability studies.
-
WHO recommendations for antiviral use for H1N1 flu; antibiotic use trends for acute respiratory tract infection; denosumab clears FDA Expert Panel; FDA Actions.
-
Aggressive approach to CVD reduces MI, folic acid and vitamin B12 for CAD, corticosteroids for acute exacerbations of COPD, prescription drug abuse among young adults, and ARBs and cancer risk.
-
Postural orthostatic tachycardia syndrome (POTS) is a disabling orthostatic intolerance that mainly occurs in pre-menopausal women.
-
The Medtronic Sprint-Fidelis ICD-lead family is associated with an increased risk for lead fracture.
-
The evolution of percutaneous coronary intervention (PCI) techniques has resulted in PCI becoming a reasonable alternative to coronary artery bypass graft (CABG) surgery in selected patients with unprotected left-main coronary artery (ULMCA) stenosis.
-
Many patients who receive pacemakers or implantable cardioverter defibrillators (ICDs) are chronically treated with antiplatelet agents, warfarin, or a combination of the two. In this paper, Tompkins and colleagues from the Johns Hopkins Hospital report the results of a retrospective review of antiplatelet and anticoagulant management in patients receiving cardiac-rhythm devices.
